Mario Mallea , Ignacio Almendras , Miguel Gallardo , Pascal Roussel , Natacha Henry , Axel Steinbrueck , Nils Metzler-Nolte , Rodrigo Arancibia
{"title":"具有抗癌潜力的1,2,4-三唑-双cp配体的同源和异核CpFe和CpRu配合物","authors":"Mario Mallea , Ignacio Almendras , Miguel Gallardo , Pascal Roussel , Natacha Henry , Axel Steinbrueck , Nils Metzler-Nolte , Rodrigo Arancibia","doi":"10.1016/j.poly.2025.117648","DOIUrl":null,"url":null,"abstract":"<div><div>A homo- and a hetero-dinuclear organometallic complex, [(Cp)Fe(Cp)-CH(Tz)-(Cp)M(Cp)] (M = Fe (<strong>3a</strong>), Ru (<strong>3b</strong>); Cp- = cyclopentadienyl, Tz = 1,2,4-triazole), were prepared from carbinol precursors [(Cp)Fe(Cp)-CH(OH)-(Cp)M(Cp)] (M = Fe (<strong>2a</strong>), Ru (<strong>2b</strong>), and 1,2,4-triazole. Complexes <strong>3a</strong>-<strong>b</strong> were characterized by <sup>1</sup>H and <sup>13</sup>C NMR spectroscopy, mass spectrometry (MS), and elemental analysis. The X-ray crystal structure of <strong>3a</strong> reveals two ferrocenyl units, whereas <strong>3b</strong> exhibits two Fe/Ru mixed-occupancy metal sites in a 1:1 ratio, along with disorder in the pendant Cp units in both structures. These findings are consistent with the MS data, which clearly show the [M]<sup>+</sup> ion for <strong>3a</strong> (Fe/Fe) and <strong>3b</strong> (Fe/Ru), but no Fe/Fe or Ru/Ru species for <strong>3b</strong>. The antiproliferative activities of <strong>3a</strong> and <strong>3b</strong> were evaluated against HeLa, MCF-7, and HT-29 cancer cell lines, with IC₅₀ values ranging from 14 to 95 μM. For comparison, cisplatin exhibited IC₅₀ values between 0.33 and 22 μM under the same conditions.</div></div>","PeriodicalId":20278,"journal":{"name":"Polyhedron","volume":"279 ","pages":"Article 117648"},"PeriodicalIF":2.4000,"publicationDate":"2025-06-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Homo- and hetero-dinuclear CpFe and CpRu complexes of a 1,2,4-triazole-bis-Cp ligand with anticancer potential\",\"authors\":\"Mario Mallea , Ignacio Almendras , Miguel Gallardo , Pascal Roussel , Natacha Henry , Axel Steinbrueck , Nils Metzler-Nolte , Rodrigo Arancibia\",\"doi\":\"10.1016/j.poly.2025.117648\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>A homo- and a hetero-dinuclear organometallic complex, [(Cp)Fe(Cp)-CH(Tz)-(Cp)M(Cp)] (M = Fe (<strong>3a</strong>), Ru (<strong>3b</strong>); Cp- = cyclopentadienyl, Tz = 1,2,4-triazole), were prepared from carbinol precursors [(Cp)Fe(Cp)-CH(OH)-(Cp)M(Cp)] (M = Fe (<strong>2a</strong>), Ru (<strong>2b</strong>), and 1,2,4-triazole. Complexes <strong>3a</strong>-<strong>b</strong> were characterized by <sup>1</sup>H and <sup>13</sup>C NMR spectroscopy, mass spectrometry (MS), and elemental analysis. The X-ray crystal structure of <strong>3a</strong> reveals two ferrocenyl units, whereas <strong>3b</strong> exhibits two Fe/Ru mixed-occupancy metal sites in a 1:1 ratio, along with disorder in the pendant Cp units in both structures. These findings are consistent with the MS data, which clearly show the [M]<sup>+</sup> ion for <strong>3a</strong> (Fe/Fe) and <strong>3b</strong> (Fe/Ru), but no Fe/Fe or Ru/Ru species for <strong>3b</strong>. The antiproliferative activities of <strong>3a</strong> and <strong>3b</strong> were evaluated against HeLa, MCF-7, and HT-29 cancer cell lines, with IC₅₀ values ranging from 14 to 95 μM. For comparison, cisplatin exhibited IC₅₀ values between 0.33 and 22 μM under the same conditions.</div></div>\",\"PeriodicalId\":20278,\"journal\":{\"name\":\"Polyhedron\",\"volume\":\"279 \",\"pages\":\"Article 117648\"},\"PeriodicalIF\":2.4000,\"publicationDate\":\"2025-06-21\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Polyhedron\",\"FirstCategoryId\":\"92\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0277538725002621\",\"RegionNum\":3,\"RegionCategory\":\"化学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"CHEMISTRY, INORGANIC & NUCLEAR\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Polyhedron","FirstCategoryId":"92","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0277538725002621","RegionNum":3,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CHEMISTRY, INORGANIC & NUCLEAR","Score":null,"Total":0}
Homo- and hetero-dinuclear CpFe and CpRu complexes of a 1,2,4-triazole-bis-Cp ligand with anticancer potential
A homo- and a hetero-dinuclear organometallic complex, [(Cp)Fe(Cp)-CH(Tz)-(Cp)M(Cp)] (M = Fe (3a), Ru (3b); Cp- = cyclopentadienyl, Tz = 1,2,4-triazole), were prepared from carbinol precursors [(Cp)Fe(Cp)-CH(OH)-(Cp)M(Cp)] (M = Fe (2a), Ru (2b), and 1,2,4-triazole. Complexes 3a-b were characterized by 1H and 13C NMR spectroscopy, mass spectrometry (MS), and elemental analysis. The X-ray crystal structure of 3a reveals two ferrocenyl units, whereas 3b exhibits two Fe/Ru mixed-occupancy metal sites in a 1:1 ratio, along with disorder in the pendant Cp units in both structures. These findings are consistent with the MS data, which clearly show the [M]+ ion for 3a (Fe/Fe) and 3b (Fe/Ru), but no Fe/Fe or Ru/Ru species for 3b. The antiproliferative activities of 3a and 3b were evaluated against HeLa, MCF-7, and HT-29 cancer cell lines, with IC₅₀ values ranging from 14 to 95 μM. For comparison, cisplatin exhibited IC₅₀ values between 0.33 and 22 μM under the same conditions.
期刊介绍:
Polyhedron publishes original, fundamental, experimental and theoretical work of the highest quality in all the major areas of inorganic chemistry. This includes synthetic chemistry, coordination chemistry, organometallic chemistry, bioinorganic chemistry, and solid-state and materials chemistry.
Papers should be significant pieces of work, and all new compounds must be appropriately characterized. The inclusion of single-crystal X-ray structural data is strongly encouraged, but papers reporting only the X-ray structure determination of a single compound will usually not be considered. Papers on solid-state or materials chemistry will be expected to have a significant molecular chemistry component (such as the synthesis and characterization of the molecular precursors and/or a systematic study of the use of different precursors or reaction conditions) or demonstrate a cutting-edge application (for example inorganic materials for energy applications). Papers dealing only with stability constants are not considered.